DE

Dan Edelstein

Chief Executive Officer

Haystack Oncology

Baltimore, Maryland


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Haystack Oncology
Industry
research
Employees
55.0
Seniority
C suite
Annual Revenue
2500000.0
Total Funding
56000000.0
Latest Funding
Series A

Technologies

CSC Corporate Domains Microsoft Office 365 Mimecast Outlook Zendesk Mobile Friendly Adobe Media Optimizer Tealium Vimeo Cedexis Radar Google Font API WordPress.org Breezy HR (formerly NimbleHR) Hubspot Google Tag Manager SharePoint AI

Keywords

biotechnology research minimal residual disease mrd testing circulating tumor dna ctdna detection ultrasensitive testing liquid biopsy residual disease detection treatment response monitoring disease recurrence surveillance personalized assay whole-exome sequencing tumor-informed approach adjuvant therapy guidance cancer genomics clinical management biopharma solutions deeper disease detection high-precision testing early detection molecular insights therapeutic development clinical trials patient outcomes next-generation sequencing mutation tracking precision oncology error rate reduction tumor mutation burden noninvasive testing monitoring therapeutic efficacy clinical utility biomarker validation risk assessment interventional data chemo-reduction strategies patient enrollment biostatistics mutation panel design archived genome library targeted therapy guidance molecular recurrence detection clinical research collaboration regulatory compliance diagnostic lab standards cutting-edge technology liquid biopsy protocols health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans